Clinical Trial

Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated September 13, 2021 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Primary end points: This clinical trial is aimed to analyze the effectiveness of Levonorgestrel-Releasing Intrauterine System (LNG-IUS, Mirena®) in the fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma, including pathology response and pregnancy outcome. Second end points: To analyze the appearances of side-effects.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2018-03-12; most recent amendment 2021-09-03.
Trial Details
NCT Number NCT03463252
Lead Sponsor West China Second University Hospital
Conditions Endometrial Cancer, Atypical Endometrial Hyperplasia
Enrollment 224 participants
Start Date 2018-04-01
Primary Completion 2025-12-30 (estimated)
Study Completion 2030-12-30 (estimated)
Updated on ClinicalTrials.gov 2021-09-13